Evidence map›Paper›PMID 33156816›Full record

ArticleAging2020

Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling.

Zhi-Chao Wang, Yan Li, Ke-Liang Wang, Lu Wang, Bo-Sen You, Dan-Feng Zhao, Zhong-Qing Liu, Rui-Zhe Fang, Jia-Qi Wang, Wei Zhang and 2 more

Open access · greenAbstract readRetraction Notice
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Zhi-Chao WangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Yan LiDepartment of Anesthesia, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Ke-Liang WangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Lu WangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Bo-Sen YouHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Dan-Feng ZhaoHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Zhong-Qing LiuHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Rui-Zhe FangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Jia-Qi WangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Wei ZhangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Jin-Ming ZhangHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Wan-Hai XuHeilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33156816
PMCPMC7655173
OpenAlexW3044383110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.